Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
Shingles drug receives clearance for final stage of testing

Shingles drug receives clearance for final stage of testing

Majority of Pennsylvania women do not seek treatments for chronic pain

Majority of Pennsylvania women do not seek treatments for chronic pain

Inhibitex announces net loss of $4.7M for fourth-quarter 2009

Inhibitex announces net loss of $4.7M for fourth-quarter 2009

Pfizer's Neurontin to earn 50% patient share in treatment of postherpetic neuralgia: Survey

Pfizer's Neurontin to earn 50% patient share in treatment of postherpetic neuralgia: Survey

XenaCare Holdings' Cobroxin to be available for purchase in Walgreens

XenaCare Holdings' Cobroxin to be available for purchase in Walgreens

Adolor announces $14.6M net product sales of ENTEREG for year ended December 31, 2009

Adolor announces $14.6M net product sales of ENTEREG for year ended December 31, 2009

EpiCept provides business update and fourth-quarter financial highlights

EpiCept provides business update and fourth-quarter financial highlights

Depomed receives final meeting minutes from FDA for pre-NDA meeting on DM-1796 for PHN

Depomed receives final meeting minutes from FDA for pre-NDA meeting on DM-1796 for PHN

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

San Antonio Methodist Hospital upgrades to Leksell Gamma Knife Perfexion system

San Antonio Methodist Hospital upgrades to Leksell Gamma Knife Perfexion system

Peripheral nerve stimulation promising for treatment of post-herpetic neuralgia

Peripheral nerve stimulation promising for treatment of post-herpetic neuralgia

CPS supports NACI recommendations for new shingles vaccine

CPS supports NACI recommendations for new shingles vaccine

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Depomed expands patent portfolio around extended release gabapentin formulation technology

Depomed expands patent portfolio around extended release gabapentin formulation technology

EpiCept's NP-1 for treatment of PHN receives FDA orphan drug designation

EpiCept's NP-1 for treatment of PHN receives FDA orphan drug designation

Endo Pharmaceuticals' partners receive Paragraph IV Certification Notice regarding LIDODERM

Endo Pharmaceuticals' partners receive Paragraph IV Certification Notice regarding LIDODERM

Watson Laboratories files ANDA for Lidoderm

Watson Laboratories files ANDA for Lidoderm

Pfizer commences recruitment for Phase I clinical trial of SA3Ag vaccine

Pfizer commences recruitment for Phase I clinical trial of SA3Ag vaccine

VELCADE sNDA receives FDA approval

VELCADE sNDA receives FDA approval

UPMC reports 10,000th patient treated using Elekta's Leksell Gamma Knife system

UPMC reports 10,000th patient treated using Elekta's Leksell Gamma Knife system